Insight Analytics Pvt. Ltd. announces the release of a market assessment report on the “Global SERD Therapeutics Market- by Products (Faslodex, RAD1901, GDC-9545, AZD9833, SAR439859 and Other Generics), Therapy (First-Line Treatment and Second-Line Treatment), Trends, Industry Competition Analysis, Revenue and Forecast To 2034.”
According to the latest research by Insight Analytics, the global SERD Therapeutics Market Size is valued at USD 1339.0 Mn in 2024 and is predicted to reach USD 2108.7 Mn by the year 2034 at a 4.8% CAGR during the forecast period for 2025-2034.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1246
A selective estrogen receptor degrader (SERD) is a medication that inhibits the estrogen receptor. SERD is used to treat estrogen-receptor-positive breast cancer. SERD therapy can be used alone or in combination with other therapeutic drugs. SERD therapy is widely recognized and utilized as monotherapy as well as in conjunction with other therapeutic medications. The entire potential of SERD therapy in breast cancer treatment has yet to be realized, providing a significant opportunity for innovation and study in the field.
The rising incidence and mortality of breast cancer, the rise in relapsed or refractory cases, the unmet clinical benefits of current breast cancer treatments targeting hormone receptor-positive metastatic breast cancer, and the rising focus of the significant players on research and development (R&D) activity for new product launch, the ease of administration and dosage exposure, and increased government funding are the main factors driving the market growth.
North America is anticipated to contribute to the SERD Therapeutics market over the years. The demand for North American SERD treatments is expanding due to rising breast cancer incidence, recurrence from current endocrine therapy, and extensive research and development in the area. In addition, the Asia Pacific SERD Therapeutics market is expected to grow significantly during the forecast period.
Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1246
Major market players operating in the SERD Therapeutics market include
Amneal Pharmaceuticals Inc, AstraZeneca, Plc., Reddy’s Laboratories, Eli Lilly and Company, G1 Therapeutics, Inc., Glenmark Pharmaceuticals, HBT Labs, Inc, Hoffmann-La Roche AG, InventisBio, Novartis AG, Radius Health, Sanofi S.A., Teva Pharmaceutical Industries Ltd., Zenopharm LLC. and Zentalis Pharmaceuticals.
Recent collaborations and agreements in the market:
- In June 2021, Verzenio® (abemaciclib), an investigational treatment for high-risk early breast cancer, and its oral selective estrogen receptor degrader (SERD) LY3484356 both saw fresh results from Eli Lilly and Company (ASCO). An exploratory analysis from the successful Phase 3 monarch research investigating the CDK4/6 inhibitor Verzenio in a subpopulation of patients with HR+, HER2-, high-risk early breast cancer (EBC) who had received neoadjuvant chemotherapy is being made public by Lilly.
- In September 2019, G1 Therapeutics, Inc. reported preliminary findings from a Phase 1/2a dose-escalation study of G1T48, an oral selective estrogen receptor degrader (SERD), in people with estrogen receptor-positive, HER2-negative (ER+, HER2-) breast cancer. In the trial, G1T48 was well tolerated and showed anti-tumor activity in patients who had received a significant amount of pretreatment. As a result of the trial’s positive findings, G1T48 will likely be developed further for use as both a first-line treatment and an adjuvant, and a first-line Phase 3 pivotal trial is anticipated to start in 2020.
For More Information @
https://www.insightaceanalytic.com/customisation/1246
Market Segments
Global SERD Therapeutics Market, by Products, 2025-2034 (Value US$ Mn)
- Faslodex
- RAD1901
- GDC-9545
- AZD9833
- SAR439859
- Other Generics
Global SERD Therapeutics Market, by Therapy, 2025-2034 (Value US$ Mn)
- First-Line Treatment
- Second-Line Treatment
Global SERD Therapeutics Market, by Region, 2025-2034 (Value US$ Mn)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
North America SERD Therapeutics Market, by Country, 2025-2034 (Value US$ Mn)
- S.
- Canada
Europe SERD Therapeutics Market, by Country, 2025-2034 (Value US$ Mn)
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific SERD Therapeutics Market, by Country, 2025-2034 (Value US$ Mn)
- India
- China
- Japan
- South Korea
- Australia & New Zealand
Latin America SERD Therapeutics Market, by Country, 2025-2034 (Value US$ Mn)
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa SERD Therapeutics Market, by Country, 2025-2034 (Value US$ Mn)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Get Mor Information :
https://www.insightaceanalytic.com/report/global-serd-therapeutics-market/1246
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
